Belgium· BE-AMP-SAM287777-00

Zostavax

A zoster virus, lebend abgeschwächt product containing varicella zoster virus, registered in Belgium by Merck Sharp & Dohme. The same ATC class is registered in 3 of our 19 countries.

ATC J07BK02

Checked against FAMHP / AFMPS (Belgium) on September 26, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about varicella zoster virusAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Zoster virus, lebend abgeschwächt is registered in 3 of 19 countries.

Countries holding a registration under ATC J07BK02 (zoster virus, lebend abgeschwächt), each read from that country’s own register.

This record: Belgium, from FAMHP / AFMPS (Belgium)
3 of them publish a price we can compare per daily dose

Search zoster virus, lebend abgeschwächt products by name

Zoster virus, lebend abgeschwächt · ATC J07BK02

3 / 19 countries

Belgiumprice
Finlandprice
Polandprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)

Active substance: Varicella Zoster Virus
Manufacturer: Merck Sharp & Dohme
Country: Belgium (BE)
ATC code: J07BK02
ATC class: Zoster Virus, lebend abgeschwächt
Reimbursed: Not published by this register
Source register: FAMHP / AFMPS (Belgium)
Last checked: September 26, 2026

Packs & prices · 1

be_apb
2324937

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Zoster virus, lebend abgeschwächt in 4 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All zoster virus, lebend abgeschwächt products

Authorised across Europe · EMA

The same active substance is authorised in 1 EEA country. Names it is sold under:

Germany · Varivax

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/58b4bf9d-e11c-49ac-b03a-4f62d4e889b6
GET /v1/drugs/58b4bf9d-e11c-49ac-b03a-4f62d4e889b6?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Powder and solvent for suspension for injection",
  "source": "afmps",
  "status": "REVOKED",
  "name_en": "Zostavax",
  "name_fr": "Zostavax",
  "name_nl": "Zostavax",
  "amp_code": "SAM287777-00",
  "strengths": null,
  "pack_count": 13,
  "substances": [
    "Varicella Zoster Virus"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Zoster, Live Attenuated",
  "authorisation_numbers": [
    "EU/1/06/341/001",
    "EU/1/06/341/003",
    "EU/1/06/341/002",
    "EU/1/06/341/005",
    "EU/1/06/341/004",
    "EU/1/06/341/007",
    "EU/1/06/341/006",
    "EU/1/06/341/009",
    "EU/1/06/341/008",
    "EU/1/06/341/011",
    "EU/1/06/341/010",
    "EU/1/06/341/013",
    "EU/1/06/341/012"
  ]
}

API reference MCP server Plans

See everything about zoster virus, lebend abgeschwächt.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console